These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 29099970)

  • 1. Expression of KIR2DS1 does not significantly contribute to NK cell cytotoxicity in HLA-C1/C2 heterozygous haplotype B donors.
    Baltner K; Kübler A; Pal M; Balvociute M; Mezger M; Handgretinger R; André MC
    Int Immunol; 2017 Nov; 29(9):423-429. PubMed ID: 29099970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity.
    Pende D; Marcenaro S; Falco M; Martini S; Bernardo ME; Montagna D; Romeo E; Cognet C; Martinetti M; Maccario R; Mingari MC; Vivier E; Moretta L; Locatelli F; Moretta A
    Blood; 2009 Mar; 113(13):3119-29. PubMed ID: 18945967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NK cell tolerance of self-specific activating receptor KIR2DS1 in individuals with cognate HLA-C2 ligand.
    Pittari G; Liu XR; Selvakumar A; Zhao Z; Merino E; Huse M; Chewning JH; Hsu KC; Dupont B
    J Immunol; 2013 May; 190(9):4650-60. PubMed ID: 23554313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1.
    Venstrom JM; Pittari G; Gooley TA; Chewning JH; Spellman S; Haagenson M; Gallagher MM; Malkki M; Petersdorf E; Dupont B; Hsu KC
    N Engl J Med; 2012 Aug; 367(9):805-16. PubMed ID: 22931314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor-recipient killer immunoglobulin like receptor (KIR) genotype matching has a protective effect on chronic graft versus host disease and relapse incidence following HLA-identical sibling hematopoietic stem cell transplantation.
    Sahin U; Dalva K; Gungor F; Ustun C; Beksac M
    Ann Hematol; 2018 Jun; 97(6):1027-1039. PubMed ID: 29549412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of alloreactive KIR2DS1(+) NK cells in haploidentical hematopoietic stem cell transplantation.
    Marcenaro E; Carlomagno S; Pesce S; Della Chiesa M; Moretta A; Sivori S
    J Leukoc Biol; 2011 Oct; 90(4):661-7. PubMed ID: 21791599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KIR2DS1-mediated activation overrides NKG2A-mediated inhibition in HLA-C C2-negative individuals.
    Foley B; De Santis D; Lathbury L; Christiansen F; Witt C
    Int Immunol; 2008 Apr; 20(4):555-63. PubMed ID: 18308713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces nonrelapse mortality.
    Mancusi A; Ruggeri L; Urbani E; Pierini A; Massei MS; Carotti A; Terenzi A; Falzetti F; Tosti A; Topini F; Bozza S; Romani L; Tognellini R; Stern M; Aversa F; Martelli MF; Velardi A
    Blood; 2015 May; 125(20):3173-82. PubMed ID: 25769621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic profiles of killer-cell immunoglobulin-like receptors and HLA ligands in Thai blood donors.
    Kitpoka P; Tammakorn C; Chaisri S; Leelayuwat C; Mongkolsuk T; Thammanichanond D
    Hum Immunol; 2016 Jun; 77(6):470-5. PubMed ID: 27131859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Donor Activating KIR-HLA Ligand-Mediated NK Cell Education Status in Control of Malignancy in Hematopoietic Cell Transplant Recipients.
    Nowak J; Kościńska K; Mika-Witkowska R; Rogatko-Koroś M; Mizia S; Jaskuła E; Polak M; Mordak-Domagała M; Lange J; Gronkowska A; Jędrzejczak WW; Kyrcz-Krzemień S; Markiewicz M; Dzierżak-Mietła M; Tomaszewska A; Nasiłowska-Adamska B; Szczepiński A; Hałaburda K; Hellmann A; Czyż A; Gil L; Komarnicki M; Wachowiak J; Barańska M; Kowalczyk J; Drabko K; Goździk J; Wysoczańska B; Bogunia-Kubik K; Graczyk-Pol E; Witkowska A; Marosz-Rudnicka A; Nestorowicz K; Dziopa J; Szlendak U; Warzocha K; Lange A;
    Biol Blood Marrow Transplant; 2015 May; 21(5):829-39. PubMed ID: 25617806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the inhibitory KIR ligand HLA-Bw4 and HLA-C expression levels in the recognition of leukemic cells by Natural Killer cells.
    Verheyden S; Ferrone S; Mulder A; Claas FH; Schots R; De Moerloose B; Benoit Y; Demanet C
    Cancer Immunol Immunother; 2009 Jun; 58(6):855-65. PubMed ID: 18841361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Relapse Risk of Acute Lymphoid Leukemia in Homozygous HLA-C1 Patients after HLA-Matched Allogeneic Transplantation: A Japanese National Registry Study.
    Arima N; Kanda J; Yabe T; Morishima Y; Tanaka J; Kako S; Sakaguchi H; Kato M; Ohashi K; Ozawa Y; Fukuda T; Ota S; Tachibana T; Onizuka M; Ichinohe T; Atsuta Y; Kanda Y
    Biol Blood Marrow Transplant; 2020 Mar; 26(3):431-437. PubMed ID: 31704471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Approach to Cell Surface Discrimination Between KIR2DL1 Subtypes and KIR2DS1 Identifies Hierarchies in NK Repertoire, Education, and Tolerance.
    Le Luduec JB; Boudreau JE; Freiberg JC; Hsu KC
    Front Immunol; 2019; 10():734. PubMed ID: 31024561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of missing KIR ligands, activating KIR genotype and haplotype on the outcome of T-cell-replete hematopoietic stem cell transplantation from HLA-identical siblings in Thai patients.
    Khanuntong S; Kuptawintu P; Upaisilpsathaporn K; Poolchareon A; Bunworasate U; Hirankarn N
    HLA; 2016 Jun; 87(6):422-31. PubMed ID: 27273744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KIR and HLA-C interactions promote differential dendritic cell maturation and is a major determinant of graft failure following kidney transplantation.
    Hanvesakul R; Kubal C; Moore J; Neil D; Cook M; Ball S; Briggs D; Moss P; Cockwell P
    PLoS One; 2011; 6(8):e23631. PubMed ID: 21912600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of missing killer cell immunoglobulin-like receptor ligands in T cell replete peripheral blood stem cell transplantation from HLA-identical siblings.
    Clausen J; Kircher B; Auberger J; Schumacher P; Ulmer H; Hetzenauer G; Wolf D; Gastl G; Nachbaur D
    Biol Blood Marrow Transplant; 2010 Feb; 16(2):273-80. PubMed ID: 19857587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-Risk Leukemia: Past, Present, and Future Role of NK Cells.
    Mavers M; Bertaina A
    J Immunol Res; 2018; 2018():1586905. PubMed ID: 29850617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor selection for killer immunoglobulin-like receptors B haplotype of the centromeric motifs can improve the outcome after HLA-identical sibling hematopoietic stem cell transplantation.
    Zhou H; Bao X; Wu X; Tang X; Wang M; Wu D; He J
    Biol Blood Marrow Transplant; 2014 Jan; 20(1):98-105. PubMed ID: 24516895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural killer cells expressing the KIR2DS1-activating receptor efficiently kill T-cell blasts and dendritic cells: implications in haploidentical HSCT.
    Sivori S; Carlomagno S; Falco M; Romeo E; Moretta L; Moretta A
    Blood; 2011 Apr; 117(16):4284-92. PubMed ID: 21355085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KIR2DS1-positive NK cells mediate alloresponse against the C2 HLA-KIR ligand group in vitro.
    Chewning JH; Gudme CN; Hsu KC; Selvakumar A; Dupont B
    J Immunol; 2007 Jul; 179(2):854-68. PubMed ID: 17617576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.